Profusa, Inc. (PFSA) stock
PFSANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NVACW
$0.35−0.06 (-14.22%)
Close on Nov 17, 2026Market cap $46.04KP/E –Yield –
Profusa operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Profusa's operating cash flow for the twelve months ending Jun 30, 2026 was -$20.33M. For fiscal 2025 it was -$16.25M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$16.25M | – |
| FY2024 | Dec 31, 2024 | -$2.07M | – |
| FY2023 | Dec 31, 2023 | -$2.06M | – |
| FY2022 | Dec 31, 2022 | -$581.19K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.63M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.58M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.13M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.99M | – |
| Q2 FY2025 | Jun 30, 2025 | -$589.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$537.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$238.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.15M | – |
| Q2 FY2024 | Jun 30, 2024 | -$394.88K | – |
| Q1 FY2024 | Mar 31, 2024 | -$280.85K | – |
| Q4 FY2023 | Dec 31, 2023 | -$345.21K | – |
| Q3 FY2023 | Sep 30, 2023 | -$479.78K | – |
| Q2 FY2023 | Jun 30, 2023 | -$273.27K | – |
| Q1 FY2023 | Mar 31, 2023 | -$966.61K | – |
| Q4 FY2022 | Dec 31, 2022 | -$179.35K | – |
| Q3 FY2022 | Sep 30, 2022 | -$107.86K | – |
| Q2 FY2022 | Jun 30, 2022 | -$63.63K | – |
| Q1 FY2022 | Mar 31, 2022 | -$230.35K | – |
See a number that looks wrong?